Both male and female beagle dogs (four dogs/sex) were orally treated with r
ifampicin (Rif) at the dose of 10 mg/kg/day for 7 days and an additional ei
ght dogs (four dogs/sex) were used as a control. The inducible effect of Ri
f on intestinal cytochrome P450, especially CYP3A enzyme, was investigated
by measuring microsomal testosterone 6 beta -hydroxylation (6 beta -OHT) ac
tivity, immunoblot and ELISA analysis. In male dogs, microsomal 6 beta -OHT
activity in the duodenum, upper, middle and lower part of the jejunum and
the ileum of the control was 229, 204, 194, 129 and 57 pmol/min/mg protein,
while the activity of the Rif-treated dogs significantly increased to 456,
486, 430, 192 and 138 pmol/min/mg protein, respectively. The activity of i
ntestinal 6 beta -OHT in the control and Rif-treated female dogs showed alm
ost similar levels to those observed in the corresponding male dogs. The ac
tivity of intestinal 6 beta -OHT in both control and Rif-treated dogs was s
pecifically inhibited by anti-CYP3A12 antiserum. The apparent K-m value for
6 beta -OHT activity in all sections of the small intestine was comparable
with that in the liver, and no significant changes: were observed in betwe
en control and Rif-treated dogs. In both control and Rif-treated dogs, immu
noblotting of intestinal microsomes with anti-CYP3A12 antiserum produced a
band indistinguishable from that of purified CYP3A12 or of immunoreactive C
YP3A12 in liver microsomes. A significant increase in intestinal CYP3A cont
ent by Rif treatment was quantitatively verified by the ELISA analysis and
the magnitude of its increase correlated well with that of 6 beta -OHT acti
vity elevation. Furthermore, the results of immunohistochemistry using the
anti-CYP3A12 antiserum indicated that CYP3A protein was specifically distri
buted in epithelial cells throughout the small intestine and appealed to he
predominant at the apical side of villus cells. These results demonstrate
that Rif induces not only hepatic CYP3A12 but also intestinal CYP3A in dogs
. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.